Vivani Medical, Inc.

Contributing Author

Recent Articles by Vivani Medical, Inc.

Sep-03	Vivani Medical Announces Participation in Upcoming Investor Conferences VANI VANI +7.19% GlobeNewswire
Aug-13	Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update VANI GlobeNewswire
Aug-06	Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management VANI GlobeNewswire
Jul-14	Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026 VANI GlobeNewswire
Jul-07	Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management VANI GlobeNewswire
Jul-02	Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc. VANI GlobeNewswire
Jun-26	Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker VANI +5.26% GlobeNewswire
Jun-25	Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management VANI -6.56% GlobeNewswire
Jun-22	Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention VANI VANI +5.31% GlobeNewswire
May-28	Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026 VANI GlobeNewswire
May-13	Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update VANI GlobeNewswire
Mar-26	Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update VANI VANI -5.56% GlobeNewswire
Jan-29	Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 VANI GlobeNewswire
Jan-27	Vivani Medical, Inc. Announces Closing of Common Stock Offering VANI VANI +7.97% GlobeNewswire
Jan-25	Vivani Medical, Inc. Announces Pricing of Common Stock Offering VANI -6.76% GlobeNewswire
Jan-22	Vivani Subsidiary Cortigent to Present Orion System's Advanced Brain Implant Technology in Poster Session at NANS 2026 VANI GlobeNewswire
Nov-13	Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results VANI -11.44% GlobeNewswire
Oct-28	Vivani Medical, Inc. Announces Closing of Common Stock Offering VANI VANI +5.99% GlobeNewswire
Oct-26	Vivani Medical, Inc. Announces Pricing of Common Stock Offering VANI GlobeNewswire
Oct-22	Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025 VANI GlobeNewswire
Oct-03	Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off VANI -8.50% GlobeNewswire
Sep-24	Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025 VANI GlobeNewswire
Sep-17	Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders VANI +19.83% GlobeNewswire
Sep-04	Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management VANI +18.10% GlobeNewswire
Aug-20	Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025 VANI GlobeNewswire
Aug-13	Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results VANI GlobeNewswire
Aug-05	Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115 VANI +7.14% GlobeNewswire
Jun-11	Vivani Medical Appoints Anthony Baldor as Chief Financial Officer VANI GlobeNewswire
Jun-10	Vivani Medical to Present at the 2025 BIO International Convention VANI GlobeNewswire
May-29	Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders VANI +5.26% GlobeNewswire
May-13	Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results VANI GlobeNewswire
May-07	Vivani Medical to Present at the American Association of Pharmaceutical Scientists' "Beyond GLP1s: Where the Science will Take Business Next" Virtual Workshop VANI GlobeNewswire

Vivani Medical, Inc.

Recent Articles by Vivani Medical, Inc.

Upgrade your Finviz experience